Viewing Study NCT04693533


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-08 @ 10:34 AM
Study NCT ID: NCT04693533
Status: RECRUITING
Last Update Posted: 2025-01-22
First Post: 2020-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fremanezumab, Migraine and Sleep
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Migraine Disorders View
None Sleep Disorder View
Keywords: